Zanubrutinib in Combination With Sonrotoclax for the Treatment of Underrepresented Ethnic and Racial Minorities With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
City of Hope Medical Center
City of Hope Medical Center
Ohio State University Comprehensive Cancer Center
National Cancer Institute (NCI)
City of Hope Medical Center
Mayo Clinic
OHSU Knight Cancer Institute
Mayo Clinic
Roswell Park Cancer Institute
Mayo Clinic
Ohio State University Comprehensive Cancer Center
OHSU Knight Cancer Institute